-
-
-
-
-
-
-
Tango Therapeutics Inc. (TNGX) PT Raised to $35 at Guggenheim
-
-
-
-
-
-
-
Tango Therapeutics Inc. (TNGX) PT Raised to $36 at Mizuho
-
-
-
-
-
-
-
Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Bernstein on US Pharma and Biotech: Who might buy whom?
-
-
-
-
-
-
-
Weakness in this biopharma stock is a buying opportunity: Leerink
-
-
-
-
-
-
-
Tango Therapeutics, Inc (TNGX) files for 1.73M share offering by selling stockholders
-
-
-
-
-
-
-
Piper Sandler Starts Tango Therapeutics Inc. (TNGX) at Overweight
-
482,960 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


